Obalon Therapeutics, Inc. (OBLN)

[r clarke]

Good point, $2.38 per share book.

.. but company needs to ramp up quicker than they appear to be doing.

Great product, but there is a limited window here before competing products emerge.










"Agreed, may be burning cash but this is trading extremely cheap against cash value. But market doesnt seem to care right now.

I will continue to be patient with adding as it starts to base.